COMBINATION OF CYCLOOXYGENASE-2 INHIBITORS AND THALIDOMIDE FOR THE TREATMENT OF NEOPLASIA

Details for Australian Patent Application No. 2003234257 (hide)

Owner PHARMACIA COPORATION

Inventors MASFERRER, Jaime, L.

Pub. Number AU-A-2003234257

PCT Number PCT/US03/13080

PCT Pub. Number WO2003/092691

Priority 10/135,793 30.04.02 US

Filing date 25 April 2003

Wipo publication date 17 November 2003

International Classifications

A61K 031/454

A61P 035/00 Antineoplastic agents

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 10/135,793 30.04.02 US

8 January 2004 Application Open to Public Inspection

  Published as AU-A-2003234257

20 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003234258-SECTIONAL CRIMPED GRAFT

2003234256-ADJUSTABLE FOCUSING COMPOSITE FOR USE IN AN OPTICAL PROFILOMETER SYSTEM AND METHOD